Shulou(Shulou.com)11/24 Report--

Thanks to CTOnews.com netizens xiaocluoyuzi and Xiao Zhan for the clue delivery! CTOnews.com February 23, according to the official website of the State Drug Administration, China's third domestic ECMO (CTOnews.com Note: its full name is Extracorporeal Membrane Oxygenation, extracorporeal membrane oxygenation) has been approved to go on the market.

On February 23, 2023, the State Drug Administration approved the registration and listing of extracorporeal cardiopulmonary support equipment developed by Jiangsu Saiteng Medical Technology Co., Ltd. This product is the third approved domestic ECMO product.

▲ pictures from Seton Medical as an emergency examination and approval product, in the registration application process, the State Drug Administration, in accordance with the principle of "unified command, early intervention, rapid and efficient, scientific examination and approval", is responsible for and guides the whole process to ensure that the products are put on the market and put into use as soon as possible.

At present, the overall performance and indicators of the three approved domestic ECMO products have basically reached the level of similar international products. The continuous approval of domestic products on the market has improved the accessibility of China's advanced life support equipment, ensured the effective supply of COVID-19 epidemic critical treatment equipment, and further met the treatment needs, while also reducing medical expenses.

In the follow-up, the drug supervision and administration department will continue to strengthen the post-market supervision of products to ensure the safety of patients using equipment.

Prior to this, Shenzhen Hannuo Medical extracorporeal cardiopulmonary support auxiliary equipment, Rocket Institute Aerospace New long March Medical Development of Huiyi-I ECMO (extracorporeal membrane oxygenator) has been approved to go on the market.

ECMO is mainly used to provide continuous extracorporeal respiration and blood circulation support for patients with severe cardiopulmonary failure. The core components generally include artificial heart (centrifugal pump mainframe and centrifugal pump head) and artificial lung (membrane lung), which can replace human heart and lung function for a long time, maintain patients' blood pressure and blood oxygen, and win valuable time for the rescue of critically ill patients.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.